| Year |
Citation |
Score |
| 2015 |
Wang Q, Qian L, Chen SH, Chu CH, Wilson B, Oyarzabal E, Ali S, Robinson B, Rao D, Hong JS. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models. Brain : a Journal of Neurology. 138: 1247-62. PMID 25716193 DOI: 10.1093/Brain/Awv034 |
0.306 |
|
| 2013 |
Biezonski DK, Piper BJ, Shinday NM, Kim PJ, Ali SF, Meyer JS. Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats. European Journal of Pharmacology. 701: 176-80. PMID 23276666 DOI: 10.1016/J.Ejphar.2012.12.024 |
0.52 |
|
| 2011 |
Liu F, Paule MG, Ali S, Wang C. Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Current Neuropharmacology. 9: 256-61. PMID 21886601 DOI: 10.2174/157015911795017155 |
0.304 |
|
| 2011 |
Shen EY, Ali SF, Meyer JS. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacology. 61: 1183-92. PMID 21763331 DOI: 10.1016/J.Neuropharm.2011.07.002 |
0.574 |
|
| 2010 |
Piper BJ, Ali SF, Daniels LG, Meyer JS. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats. Synapse (New York, N.Y.). 64: 421-31. PMID 20169574 DOI: 10.1002/Syn.20744 |
0.586 |
|
| 2009 |
Tareke E, Lyn-Cook BD, Duhart H, Newport G, Ali S. Acrylamide decreased dopamine levels and increased 3-nitrotyrosine (3-NT) levels in PC 12 cells. Neuroscience Letters. 458: 89-92. PMID 19442880 DOI: 10.1016/J.Neulet.2009.04.016 |
0.301 |
|
| 2008 |
Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1192-205. PMID 17609680 DOI: 10.1038/Sj.Npp.1301491 |
0.568 |
|
| 2006 |
Meyer JS, Brevard ME, Piper BJ, Ali SF, Ferris CF. Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. Annals of the New York Academy of Sciences. 1074: 365-76. PMID 17105934 DOI: 10.1196/Annals.1369.036 |
0.514 |
|
| 2004 |
Meyer JS, Grande M, Johnson K, Ali SF. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 22: 261-71. PMID 15380826 DOI: 10.1016/j.ijdevneu.2004.04.007 |
0.55 |
|
| 2003 |
Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Annals of the New York Academy of Sciences. 993: 197-207; discussion . PMID 12853314 DOI: 10.1111/J.1749-6632.2003.Tb07530.X |
0.306 |
|
| 2002 |
Meyer JS, Ali SF. Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain. Annals of the New York Academy of Sciences. 965: 373-80. PMID 12105113 DOI: 10.1111/J.1749-6632.2002.Tb04179.X |
0.526 |
|
| 2002 |
Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Annals of the New York Academy of Sciences. 965: 225-32. PMID 12105098 DOI: 10.1111/J.1749-6632.2002.Tb04164.X |
0.308 |
|
| 1996 |
Sheng P, Cerruti C, Ali S, Cadet JL. Nitric Oxide Is a Mediator of Methamphetamine (METH)‐Induced Neurotoxicity Annals of the New York Academy of Sciences. 801: 174-186. PMID 8959032 DOI: 10.1111/J.1749-6632.1996.Tb17440.X |
0.305 |
|
| Show low-probability matches. |